Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,141 GBX | -0.40% | +1.15% | +14.77% |
11:35am | AstraZeneca: CHMP recommends approval of Tagrisso in the EU | CF |
11:19am | AstraZeneca's Tagrisso Reduces Lung Cancer Progression in Phase 3 Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 240B | |
+40.73% | 739B | |
+31.74% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+9.54% | 210B | |
-4.79% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca to Develop $1.5 Billion Singapore Manufacturing Facility